SCHEMBL309669

SCHEMBL309669

[O]c1c(-c2ccccc2)cc(-c2ccccc2)cc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.50
ALDH1A1 P00352 4/20 0.47
BACE1 P56817 1/20 0.46
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
APAF1 O14727 1/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
XBP1 P17861 1/20 0.45
PTBP1 P26599 1/20 0.45
RAB9A P51151 1/20 0.45
GALK1 P51570 1/20 0.45
BLM P54132 1/20 0.45
SMAD3 P84022 1/20 0.45
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15509351 0.80 METAP2 (0.55) ALDH1A1BACE1SMN1; SMN2LMNAMAPT
SCHEMBL15509310 0.80 AKR1C3 (0.53) ALDH1A1BACE1HTTMAPTMAOB
SCHEMBL15509479 0.80 METAP2 (0.55) BACE1HTTMEN1NPC1LMNA
SCHEMBL15509632 0.80 METAP2 (0.55) ALDH1A1BACE1HTTMEN1LMNA
SCHEMBL199940 0.78 ALDH1A1 (0.48) ALDH1A1BACE1KMT2AHSD17B10HPGD
SCHEMBL8928083 0.76 ALDH1A1 (0.50) PTPN1ALDH1A1BACE1HTTSMN1; SMN2
SCHEMBL16050857 0.75 PSMB5 (0.44) ALDH1A1BACE1HTTSMN1; SMN2MEN1
SCHEMBL22064851 0.74 CYP2A6 (0.50) PTPN1ALDH1A1BACE1HTTSMN1; SMN2
SCHEMBL22064850 0.74 ALDH1A1 (0.47) PTPN1ALDH1A1BACE1HTTSMN1; SMN2
SCHEMBL20663065 0.74 PTGS1 (0.58) PTPN1ALDH1A1BACE1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3662996-A2 MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS Verbio Vereinigte BioEnergie AG (DE) 2020-06-10 EP claimed
EP-2703081-B1 MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS XIMO AG (CH) 2019-08-07 EP claimed
US-9919299-B2 Metathesis catalysts and reactions using the catalysts XIMO AG (CH) 2018-03-20 US claimed
US-9499455-B2 Process for the selective dimerisation of ethylene to 1-butene IFP Energies Nouvelles (FR) 2016-11-22 US claimed
US-20160030936-A1 METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS VERBIO SE (DE) 2016-02-04 US claimed
EP-2969204-A2 MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS XiMo AG (CH) 2016-01-20 EP claimed
US-20140309466-A1 METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS VERBIO SE (DE) 2014-10-16 US claimed
WO-2014139679-A2 METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS XIMO AG (CH) 2014-09-18 WO claimed
EP-2703081-A1 Molybdenum and tungsten complexes as olefin metathesis catalysts and reactions using the catalysts XiMo AG (CH) 2014-03-05 EP claimed
US-7148296-B2 Capped poly(arylene ether) composition and process GENERAL ELECTRIC COMPANY (US) 2006-12-12 US claimed
US-7101923-B2 Flame-retardant thermoset composition, method, and article GENERAL ELECTRIC COMPANY (US) 2006-09-05 US claimed
US-20060167142-A9 FLAME-RETARDANT THERMOSET COMPOSITION, METHOD, AND ARTICLE GENERAL ELECTRIC COMPANY 2006-07-27 US claimed
US-7067595-B2 Poly (arylene ether) composition and method GENERAL ELECTRIC COMPANY (US) 2006-06-27 US claimed
WO-2006023371-A1 FUNCTIONALIZED POLY(ARYLENE ETHER) COMPOSITION AND METHOD GENERAL ELECTRIC COMPANY (US) 2006-03-02 WO claimed
US-20060041086-A1 Functionalized poly(arylene ether) composition and method SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2006-02-23 US claimed
US-6903042-B2 Catalytic composition and process for oligomerizing ethylene, in particular to 1-hexene INSTITUT FRANCAIS DU PETROLE (FR) 2005-06-07 US claimed
US-20050075426-A1 Flame-retardant thermoset composition, method, and article CITIBANK, N.A., AS COLLATERAL AGENT 2005-04-07 US claimed
US-20050075463-A1 Poly (arylene ether) composition and method CITIBANK, N.A., AS COLLATERAL AGENT 2005-04-07 US claimed
US-20050075427-A1 Flame-retardant thermoset composition, method, and article GENERAL ELECTRIC COMPANY 2005-04-07 US claimed
US-20050075462-A1 Capped poly(arylene ether) composition and process SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2005-04-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309466-A1 METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS MSMO1, PYM1, SQLE PTPN1 4326/4885ALDH1A1 2361/4885BACE1 1981/4885
US-20160030936-A1 METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS MSMO1, SQLE, PYM1 PTPN1 4333/4885ALDH1A1 1956/4885BACE1 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.